Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

DNA methylation haplotypes as cancer markers

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Distribution of the estimated whole blood cfDNA proportions in normal, colorectal cancer and lung cancer plasma.

References

  1. 1.

    Guo, S. et al. Nat. Genet. 49, 635–642 (2017).

    CAS  Article  Google Scholar 

  2. 2.

    Sun, K. et al. Proc. Natl. Acad. Sci. USA 112, E5503–E5512 (2015).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to John M. Greally.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Seoighe, C., Tosh, N.J. & Greally, J.M. DNA methylation haplotypes as cancer markers. Nat Genet 50, 1062–1063 (2018). https://doi.org/10.1038/s41588-018-0185-x

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing